Eli Lilly And Company (LLY) fundamentals from SEC filings — revenue $65.2B, net margin 31.7%, diluted EPS $22.95 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| Net income | $5.6B | $6.2B | $5.2B | $10.6B | $20.6B |
| Net margin | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% |
| Diluted EPS | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |
| Free cash flow | $6.1B | $5.7B | $792.0M | $3.8B | $9.0B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home